These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2406790)

  • 1. New tools of the trade.
    Reamer LA
    Radiology; 1990 Mar; 174(3 Pt 2):923-5. PubMed ID: 2406790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U.S. Food and Drug Administration and regulation of medical devices in radiology.
    Pritchard WF; Carey RF
    Radiology; 1997 Oct; 205(1):27-36. PubMed ID: 9314955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
    Tylenda CA; Weintraub M
    Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the regulatory aspects of medical devices from the viewpoint of research and device manufacturing.
    Patrick J
    Reg Anesth; 1993; 18(6 Suppl):424-7. PubMed ID: 8110642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices: US medical device regulation.
    Jarow JP; Baxley JH
    Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ABCs of the FDA: A Primer on the Role of the United States Food and Drug Administration in Medical Device Approvals and IR Research.
    Adamovich A; Park S; Siskin GP; Englander MJ; Mandato KD; Herr A; Keating LJ
    J Vasc Interv Radiol; 2015 Sep; 26(9):1324-30. PubMed ID: 26189046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and Drug Administration regulation of in vitro diagnostic devices.
    Mansfield E; O'Leary TJ; Gutman SI
    J Mol Diagn; 2005 Feb; 7(1):2-7. PubMed ID: 15681468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making sense of the food and drug administration.
    Connor JA
    Semin Pediatr Surg; 2006 Nov; 15(4):293-301. PubMed ID: 17055960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; exemptions from premarket notification; class II devices. Final rule.
    Food and drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57368-9. PubMed ID: 11776279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; investigational device exemptions--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthopaedic Device Approval Through the Premarket Approval Process: A Financial Feasibility Analysis for a Single Center.
    Yang BW; Iorio ML; Day CS
    J Bone Joint Surg Am; 2017 Mar; 99(6):e26. PubMed ID: 28291189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
    Yin L
    J Reprod Med; 1983 Jan; 28(1):3-11. PubMed ID: 6834344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to the Food and Drug Administration (FDA) regulatory process.
    Hackett JL; Gutman SI
    J Proteome Res; 2005; 4(4):1110-3. PubMed ID: 16083260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory issues relating to therapies for periodontal regeneration.
    Singleton DG; Torres-Cabassa A
    Ann Periodontol; 1997 Mar; 2(1):223-8. PubMed ID: 9151556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.